Clinical Trial 42563

New Port Richey, FL 34652


Study 42563 Flyer
Click image to enlarge

We are seeking volunteers, age 18 and over, to participate in a research study comparing an investigational fast-acting insulin with NovoLog®.

You may qualify if you:

· Are currently taking insulin glargine, also known as Lantus®  

· Use NovoLog® for bolus insulin at least 3 times per day

Participants not meeting this criterion may also qualify, provided that they complete the run-in period during which NovoLog and Lantus will be administered so that, at the time of randomization, the participants have been on NovoLog and insulin glargine (100 U/mL) for at least 12 weeks (including any potential pre-screening administration).


Alternating use of SAR341402 and NovoLog, self-administered by subcutaneous injection at mealtime, starting with NovoLog for the first 4 weeks, then SAR341402 for 4 weeks, followed by NovoLog for 4 weeks and then SAR341402 for the last 4 weeks on top of Lantus as basal insulin.


Continuous use of NovoLog, self-administrated by subcutaneous injection at mealtime, during the 16-week Treatment Period on top of Lantus as basal insulin.

Qualified Participants May Receive:

· Lantus® and investigational fast-acting insulin and/or NovoLog® (no placebo)

· Glucometer and testing supplies

· Payment for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.